Committee on Clinical Pharmacy as a Specialty. Summary of petition requesting recognition of clinical pharmacy as a specialty. Am J Hosp Pharm1986; 43: 1267–77.
2.
BenderGA. Great moments in pharmacy, 2nd ed. Detroit: Northwood Institute Press, 1967: 28–9.
3.
JuskoWJ. The role of the pharmacist in clinical research. In: BreimerDDSpeiserP, eds. Topics in pharmaceutical sciences 1985. Amsterdam: Elsevier, 1985: 417–30.
4.
TurcoSJCanadaAT. The effects of dimethyl sulfoxide in lowering electrical skin resistance. Am J Hosp Pharm1969; 26: 120–2.
5.
PuckettWHViscontiJA. An epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. Am J Hosp Pharm1971; 28: 247–53.
6.
BarrWHGerbrachtLMLetcherKPlautMStrahlN. Assessment of the biologic availability of tetracycline products in man. Clin Pharmacol Ther1972; 13: 97–107.
7.
KupferbergHJJefferyWHunninghakeDB. Effect of methylphenidate on plasma anticonvulsant levels. Clin Pharmacol Ther1972; 13: 201–4.
8.
FleckensteinLKroeningBWeintraubM. Assessment of the biologic availability of digoxin in man. Clin Pharmacol Ther1974; 16: 435–43.
9.
Pharmacists for the future. The report of the Study Commission on Pharmacy. Ann Arbor, MI: Health Administration Press, 1975: 123–5.
10.
EvansWE. The clinical pharmacists and research. J Clin Pharmacol1981; 21: 241–4.
11.
NightingaleSL. Clinical pharmacists as principal investigators (letter). Drug Intell Clin Pharm1983; 17: 676.
12.
HatoumHTCatizoneCHutchinsonRAPurohitA. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm1986; 20: 33–48.
13.
KaulAFPowellSHCyrDA. Postgraduate pharmacy fellowships. Drug Intell Clin Pharm1981; 15: 981–5.
OatesJA. Clinical pharmacologists for the future in the United States. Clin Pharmacol Ther1986; 39: 462–5.
16.
Office of Management and Budget. Special analysis of the budget of the United States government—fiscal 1987; section D21.
17.
MossinghoffGJ. Federal and international developments affecting the pharmaceutical industry. Pharmaceutical Public Policy Conference, University of Minnesota, Minneapolis, MN, June 26, 1986.